Can a drug to treat diabetes and a drug to treat hypertension be an effective anti-cancer combination?
Data is preliminary and still being tested in mouse models, but a recent paper in Science Advances details that combining a diabetes drug, metformin, with an anti-hyptertensive, syrosingopine, may work to prevent cancer cell growth. The December publication by Don Benjamin and colleagues shows how these two common drugs may interact. Metformin is a common diabetes drug that has been shown to have anti-cancer properties. (see Evans, Libby, Jiralerspong, DeCensi, and Noto. It is... Read More